Cocrystal Pharma, Inc. Earnings Per Share Diluted

• Cocrystal Pharma, Inc. showed an increase of +54.7% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from Cocrystal Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2013 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2013 to 2025), Cocrystal Pharma, Inc.'s Earnings Per Share Diluted has declined by 1,014.3%.
• Historical annual values: Fiscal year 2025: $0.78 (loss) per share | Fiscal year 2024: $1.72 (loss) per share | Fiscal year 2023: $1.87 (loss) per share | Fiscal year 2022: $4.77 (loss) per share | Fiscal year 2017: $0.03 (loss) per share | Fiscal year 2016: $3.30 (loss) per share | Fiscal year 2015: $2.40 (loss) per share | Fiscal year 2014: $0.01 (loss) per share | Fiscal year 2013: $0.07 (loss) per share.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026